Structural and functional characterization of the zebrafish gene for glial fibrillary acidic protein, GFAP
- PMID: 12801639
- DOI: 10.1016/s0378-1119(03)00526-2
Structural and functional characterization of the zebrafish gene for glial fibrillary acidic protein, GFAP
Abstract
Glial fibrillary acidic protein, GFAP, is an astrocyte-specific member of the family of intermediate filament proteins which are involved in formation of the cytoskeletal structure. We here present a characterization of the zebrafish GFAP gene and corresponding protein. The zebrafish GFAP gene have the same exon-intron organization as the mammalian orthologoue genes. Comparison of the protein with mammalian GFAP shows that the amino acid sequence is highly conserved in the rod and tail domains whereas the head domain has diverged. Zebrafish GFAP exhibits functional characteristics of an intermediate filament protein such as dimerization potential, capacity to assembly into filaments, and cytoskeletal localization. Mutations in human GFAP have been associated with a severe childhood brain disorder called Alexander disease. Interestingly, the mutations affect preferentially amino acid residues of GFAP that are evolutionarily conserved. This indicates that a change of functionally core residues in GFAP is a prerequisite for the disease phenotype to develop and the initial steps in the pathogenesis may thus be modeled in zebrafish.
Similar articles
-
Deletions in Glial Fibrillary Acidic Protein Leading to Alterations in Intermediate Filament Assembly and Network Formation.Int J Mol Sci. 2025 Feb 23;26(5):1913. doi: 10.3390/ijms26051913. Int J Mol Sci. 2025. PMID: 40076540 Free PMC article.
-
Effects of Alexander disease-associated mutations on the assembly and organization of GFAP intermediate filaments.Mol Biol Cell. 2022 Jul 1;33(8):ar69. doi: 10.1091/mbc.E22-01-0013. Epub 2022 May 5. Mol Biol Cell. 2022. PMID: 35511821 Free PMC article.
-
Novel mutations in exon 6 of the GFAP gene affect a highly conserved if motif in the rod domain 2B and are associated with early onset infantile Alexander disease.Neuropediatrics. 2007 Jun;38(3):143-7. doi: 10.1055/s-2007-985902. Neuropediatrics. 2007. PMID: 17985264
-
GFAP at 50.ASN Neuro. 2020 Jan-Dec;12:1759091420949680. doi: 10.1177/1759091420949680. ASN Neuro. 2020. PMID: 32811163 Free PMC article. Review.
-
GFAP mutations in Alexander disease.Int J Dev Neurosci. 2002 Jun-Aug;20(3-5):259-68. doi: 10.1016/s0736-5748(02)00019-9. Int J Dev Neurosci. 2002. PMID: 12175861 Review.
Cited by
-
Pamiparib Induces Neurodevelopmental Defects and Cerebral Haemorrhage in Zebrafish Embryos via Inhibiting Notch Signalling.Mol Neurobiol. 2022 Nov;59(11):6652-6665. doi: 10.1007/s12035-022-02988-z. Epub 2022 Aug 19. Mol Neurobiol. 2022. PMID: 35982279
-
Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.BMC Neurol. 2017 Sep 7;17(1):175. doi: 10.1186/s12883-017-0938-7. BMC Neurol. 2017. PMID: 28882119 Free PMC article.
-
Expression and function of nr4a2, lmx1b, and pitx3 in zebrafish dopaminergic and noradrenergic neuronal development.BMC Dev Biol. 2007 Dec 5;7:135. doi: 10.1186/1471-213X-7-135. BMC Dev Biol. 2007. PMID: 18053265 Free PMC article.
-
Alexander Disease Modeling in Zebrafish: An In Vivo System Suitable to Perform Drug Screening.Genes (Basel). 2020 Dec 11;11(12):1490. doi: 10.3390/genes11121490. Genes (Basel). 2020. PMID: 33322348 Free PMC article.
-
Neurotoxicity and Mechanism in Zebrafish Embryo Induced by Tetrabromobisphenol A bis (2-Hydroxyethyl) Ether (TBBPA-DHEE) Exposure.Toxics. 2025 Jan 22;13(2):76. doi: 10.3390/toxics13020076. Toxics. 2025. PMID: 39997892 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous